Works matching Antimetabolites


Results: 2956
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial.

    Published in:
    Journal of Ophthalmic Inflammation & Infection, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s12348-023-00350-5
    By:
    • Reddy, Amit K.;
    • Miller, D. Claire;
    • Sura, Amol A.;
    • Rathinam, SR;
    • Gonzales, John A;
    • Thundikandy, Radhika;
    • Kanakath, Anuradha;
    • Murugan, Bala;
    • Vedhanayaki, Rajesh;
    • Lim, Lyndell L.;
    • Suhler, Eric B.;
    • Doan, Thuy;
    • Al-Dhibi, Hassan A.;
    • Goldstein, Debra A.;
    • Arellanes-Garcia, Lourdes;
    • Acharya, Nisha R
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50